Citations (43)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (15)
Ann Childress, Robert Sottile & Sherine Khanbijian. (2023) Viloxazine extended-release capsules for the treatment of attention-deficit/ hyperactivity disorder in adult patients. Expert Review of Neurotherapeutics 23:11, pages 945-953.
Read now
Read now
Mustafa Tuncturk, Cagatay Ermis, Dicle Buyuktaskin, Eren Halac, Ekin Sut, Oben Ozkan, Nazan Gundogan, Guldal Unutmaz, R. Ogulcan Ciray, Serkan Turan & Aynur Akay Pekcanlar. (2023) Investigating the effects of age, IQ, dosing, and anthropometric measures on the treatment persistence in long-term methylphenidate use. Nordic Journal of Psychiatry 77:4, pages 345-351.
Read now
Read now
Muhammad Umair Khan, Camila Balbontin, Michiel Bliemer & Parisa Aslani. (2023) Using discrete choice experiment to investigate patients’ and parents’ preferences for initiating ADHD medication. Journal of Mental Health 32:2, pages 373-385.
Read now
Read now
Jeff Schein, Martin Cloutier, Marjolaine Gauthier-Loiselle, Rebecca Bungay, Annie Guerin & Ann Childress. (2023) Symptoms associated with ADHD/treatment-related adverse side effects and their impact on quality of life and work productivity in adults with ADHD. Current Medical Research and Opinion 39:1, pages 149-159.
Read now
Read now
Jeff Schein, Lenard A. Adler, Ann Childress, Martin Cloutier, Patrick Gagnon-Sanschagrin, Mikhaïl Davidson, Frédéric Kinkead, Annie Guerin & Patrick Lefebvre. (2022) Economic burden of attention-deficit/hyperactivity disorder among children and adolescents in the United States: a societal perspective. Journal of Medical Economics 25:1, pages 193-205.
Read now
Read now
Jeff Schein, Ann Childress, Julie Adams, Martin Cloutier, Patrick Gagnon-Sanschagrin, Jessica Maitland, Rebecca Bungay, Annie Guérin & Patrick Lefebvre. (2021) Treatment patterns among adults with attention-deficit/hyperactivity disorder in the United States: a retrospective claims study. Current Medical Research and Opinion 37:11, pages 2007-2014.
Read now
Read now
Christina Mohr-Jensen, Anne-Mette Lange, Per Hove Thomsen & David Daley. (2020) Treatment of ADHD in adults – prevalence of discontinuation and associated factors – results from a cross-sectional analysis of Danish register data. Nordic Journal of Psychiatry 74:7, pages 479-488.
Read now
Read now
Megan Barnett & Louise Reid. (2020) The effectiveness of methylphenidate in improving cognition after brain injury in adults: a systematic review. Brain Injury 34:1, pages 1-10.
Read now
Read now
Wen-Jiun Chou, Liang-Jen Wang, Chien-Ho Lin, Sun-Yuan Liang, Vincent Chin-Hung Chen, Yuh-Ming Hou, Rong-Rong Huang, Miao-Chun Chou, Chi-Yung Shang, Chi-Pui Ho & Meng-Chuan Lai. (2018) Social adjustment and family function after drug switch from IR-methylphenidate to OROS-methylphenidate in patients with attention-deficit/hyperactivity disorder. Neuropsychiatric Disease and Treatment 14, pages 2783-2791.
Read now
Read now
Hideyuki Imagawa, Saurabh P Nagar, William Montgomery, Tomomi Nakamura, Masayo Sato & Keith L Davis. (2018) Treatment patterns, health care resource utilization, and costs in Japanese adults with attention-deficit hyperactivity disorder treated with atomoxetine. Neuropsychiatric Disease and Treatment 14, pages 611-621.
Read now
Read now
Cliff Molife, Virginia S. Haynes, Allen Nyhuis, Douglas E. Faries, Steve Gelwicks, Douglas K. Kelsey & Carlos I. Alatorre. (2018) Healthcare utilization and costs of children with attention deficit/hyperactivity disorder initiating atomoxetine versus extended-release guanfacine. Current Medical Research and Opinion 34:4, pages 619-632.
Read now
Read now
Michael Huss, Praveen Duhan, Preetam Gandhi, Chien-Wei Chen, Carsten Spannhuth & Vinod Kumar. (2017) Methylphenidate dose optimization for ADHD treatment: review of safety, efficacy, and clinical necessity. Neuropsychiatric Disease and Treatment 13, pages 1741-1751.
Read now
Read now
Yu-Shian Cheng, Yu-Chiau Shyu, Sheng-Yu Lee, Shin-Sheng Yuan, Chun-Ju Yang, Kang-Chung Yang, Tung-Liang Lee & Liang-Jen Wang. (2017) Trend, characteristics, and pharmacotherapy of adults diagnosed with attention-deficit/hyperactivity disorder: a nationwide survey in Taiwan. Neuropsychiatric Disease and Treatment 13, pages 643-651.
Read now
Read now
Gregory W Mattingly, Joshua Wilson & Anthony L Rostain. (2017) A clinician’s guide to ADHD treatment options. Postgraduate Medicine 129:7, pages 657-666.
Read now
Read now
Alain Joseph, Martin Cloutier, Annie Guérin, Roy Nitulescu & Vanja Sikirica. (2016) Treatment outcomes after methylphenidate in adults with attention-deficit/hyperactivity disorder treated with lisdexamfetamine dimesylate or atomoxetine. Patient Preference and Adherence 10, pages 391-405.
Read now
Read now
Articles from other publishers (28)
Ashley E. Teasdale, Petra A. Duran & Marni E. Axelrad. (2022) Effectiveness of Clinic-Based Brief Behavioral Intervention (BBI) in Long-term Reduction of ADHD Symptoms Among Preschoolers. Journal of Clinical Psychology in Medical Settings 30:2, pages 403-414.
Crossref
Crossref
Elizabeth Wall-Wieler, James M. Bolton, Gilles Detillieux & Leslie L. Roos. (2021) Use of Medication to Treat Attention-Deficit/Hyperactivity Disorder in Young Children: The Role of Maternal History of Psychotropic Medication Use. Child Psychiatry & Human Development 54:2, pages 283-289.
Crossref
Crossref
Mahasweta Chatterjee, Sharmistha Saha, Subhamita Maitra, Anirban Ray, Swagata Sinha & Kanchan Mukhopadhyay. (2023)
Post-treatment symptomatic improvement of the eastern Indian ADHD probands is influenced by
CYP2D6
genetic variations
. Drug Metabolism and Personalized Therapy 38:1, pages 45-56.
Crossref
Crossref
Bruna Santos da Silva, Eugenio Horacio Grevet, Luiza Carolina Fagundes Silva, João Kleber Neves Ramos, Diego Luiz Rovaris & Claiton Henrique Dotto Bau. (2023) An overview on neurobiology and therapeutics of attention-deficit/hyperactivity disorder. Discover Mental Health 3:1.
Crossref
Crossref
Amy Glasofer & Catherine Dingley. (2021) Diagnostic and Medication Treatment Disparities in African American Children with ADHD: a Literature Review. Journal of Racial and Ethnic Health Disparities 9:5, pages 2027-2048.
Crossref
Crossref
Daniel Titheradge, Jo Godfrey, Helen Eke, Anna Price, Tamsin Ford & Astrid Janssens. (2022) Why young people stop taking their attention deficit hyperactivity disorder medication: A thematic analysis of interviews with young people. Child: Care, Health and Development 48:5, pages 724-735.
Crossref
Crossref
Ruu-Fen Tzang & Yue-Cune Chang. (2022) Generalized structural equation modeling: Symptom heterogeneity in attention-deficit/hyperactivity disorder leading to poor treatment efficacy. World Journal of Psychiatry 12:6, pages 787-800.
Crossref
Crossref
Amanda Stueber & Carrie Cuttler. (2021) Self-Reported Effects of Cannabis on ADHD Symptoms, ADHD Medication Side Effects, and ADHD-Related Executive Dysfunction. Journal of Attention Disorders 26:6, pages 942-955.
Crossref
Crossref
Raman Baweja, Cesar A Soutullo & James G Waxmonsky. (2021) Review of barriers and interventions to promote treatment engagement for pediatric attention deficit hyperactivity disorder care. World Journal of Psychiatry 11:12, pages 1206-1227.
Crossref
Crossref
Alessandro Pallucchini, Marco Carli, Angelo Maremmani, Marco Scarselli, Giulio Perugi & Icro Maremmani. (2021) Influence of Substance Use Disorder on Treatment Retention of Adult-Attention-Deficit/Hyperactive Disorder Patients. A 5-Year Follow-Up Study. Journal of Clinical Medicine 10:9, pages 1984.
Crossref
Crossref
W. David Lohr, Jonathon W. Wanta, Megan Baker, Eugene Grudnikoff, Wynne Morgan, Divya Chhabra & Terry Lee. (2021) Intentional Discontinuation of Psychostimulants Used to Treat ADHD in Youth: A Review and Analysis. Frontiers in Psychiatry 12.
Crossref
Crossref
Mike Thelwall, Meiko Makita, Amalia Mas-Bleda & Emma Stuart. (2021) “My ADHD Hellbrain”: A Twitter Data Science Perspective on a Behavioural Disorder. Journal of Data and Information Science 6:1, pages 13-34.
Crossref
Crossref
Ping Mamiya, Anne Arnett & Mark Stein. (2021) Precision Medicine Care in ADHD: The Case for Neural Excitation and Inhibition. Brain Sciences 11:1, pages 91.
Crossref
Crossref
Antonio Olry de Labry Lima, Jorge Marcos Marcos, Alfonso Marquina Marquez, María de los Ángeles González Vera, Antonio Matas Hoces & Clara Bermúdez Tamayo. (2020) Evidence for deprescription in primary care through an umbrella review. BMC Family Practice 21:1.
Crossref
Crossref
Xiaofei Zheng, Li Shen, Lian Jiang, Xiao Shen, Ying Xu, Guangjun Yu & Yu Wang. (2020) Parent and Teacher Training Increases Medication Adherence for Primary School Children With Attention-Deficit/Hyperactivity Disorder. Frontiers in Pediatrics 8.
Crossref
Crossref
Chih-Cheng Chang, Yu-Min Chen, Tai-Ling Liu, Ray C. Hsiao, Wen-Jiun Chou & Cheng-Fang Yen. (2020) Affiliate Stigma and Related Factors in Family Caregivers of Children with Attention-Deficit/Hyperactivity Disorder. International Journal of Environmental Research and Public Health 17:2, pages 576.
Crossref
Crossref
Stefano Pallanti & Luana SalernoStefano Pallanti & Luana Salerno. 2020. The Burden of Adult ADHD in Comorbid Psychiatric and Neurological Disorders. The Burden of Adult ADHD in Comorbid Psychiatric and Neurological Disorders
97
118
.
Tamsin Newlove-Delgado, Tamsin J. Ford, Willie Hamilton, Astrid Janssens, Ken Stein & Obioha C. Ukoumunne. (2019) Resumption of attention-deficit hyperactivity disorder medication in early adulthood: findings from a UK primary care prescribing study. European Child & Adolescent Psychiatry 28:12, pages 1589-1596.
Crossref
Crossref
Jūratė Kuzmickaitė, Darius Leskauskas & Ona Gylytė. (2019) ADHD-Related Mental Health Issues of Young Adult Male Prisoners in Pravieniškės Correction House-Open Colony (Lithuania). American Journal of Men's Health 13:4, pages 155798831987097.
Crossref
Crossref
Kee Jeong Park & Hyo-Won Kim. (2019) Clinical and Neuropsychological Factors Associated with Treatment Response and Adverse Events of Atomoxetine in Children with Attention-Deficit/Hyperactivity Disorder. Journal of the Korean Academy of Child and Adolescent Psychiatry 30:2, pages 74-82.
Crossref
Crossref
Amos Fleischmann & Sharief Dabbah. (2018) Negev Bedouin Teachers’ Attitudes Toward ADHD and Its Pharmacological Treatment. Qualitative Health Research 29:3, pages 418-430.
Crossref
Crossref
Luana Salerno & J. J. Sandra Kooij. 2019. Psychopathology in Adolescents and Adults with Autism Spectrum Disorders. Psychopathology in Adolescents and Adults with Autism Spectrum Disorders
175
194
.
Kyeong Eun Lee & Nam Kyung Je. (2018) Patterns and Persistence of Pharmacotherapy for Children and Adolescents with Attention Deficit Hyperactivity Disorder in South Korea. Korean Journal of Clinical Pharmacy 28:3, pages 216-223.
Crossref
Crossref
Iana Y. T. Wong, David J. Hawes, Simon Clarke, Michael R. Kohn & Ilan Dar-Nimrod. (2017) Perceptions of ADHD Among Diagnosed Children and Their Parents: A Systematic Review Using the Common-Sense Model of Illness Representations. Clinical Child and Family Psychology Review 21:1, pages 57-93.
Crossref
Crossref
Swapna Deshpande, Britta Ostermeyer, Akshay Lokhande, Humaira Abid & Asim A. Shah. (2017) Managing Adult Attention-Deficit/Hyperactivity Disorder: To Treat or Not To Treat?. Psychiatric Annals 47:6, pages 315-321.
Crossref
Crossref
Cornelia Soff, Anna Sotnikova, Hanna Christiansen, Katja Becker & Michael Siniatchkin. (2016) Transcranial direct current stimulation improves clinical symptoms in adolescents with attention deficit hyperactivity disorder. Journal of Neural Transmission 124:1, pages 133-144.
Crossref
Crossref
Tor-Arne Hegvik, Kaya Kvarme Jacobsen, Mats Fredriksen, Tetyana Zayats & Jan Haavik. (2016) A candidate gene investigation of methylphenidate response in adult attention-deficit/hyperactivity disorder patients: results from a naturalistic study. Journal of Neural Transmission 123:8, pages 859-865.
Crossref
Crossref
Hanne Cecilie Kaspersen & Berit Hjelde Hansen. (2015) Er retningslinjene for oppfølging av AD/HD gode nok?. Tidsskrift for Den norske legeforening 135:21, pages 1929-1930.
Crossref
Crossref